Eiger BioPharmaceuticals: Q4 Earnings Insights

Eiger BioPharmaceuticals EIGR reported its Q4 earnings results on Thursday, March 10, 2022 at 04:01 PM.

Here's what investors need to know about the announcement.

Earnings

Eiger BioPharmaceuticals reported in-line EPS of $-0.64 versus an estimate of $-0.64.

Revenue was up $3.36 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.09 which was followed by a 3.02% increase in the share price the next day.

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.